Plandai Biotechnolog
Plandai Biotechnology Enters Medical Marijuana Arena With Industry-Changing Technology
October 31, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 31, 2013) - Plandaí Biotechnolgy, Inc. (OTCQB: PLPL) announced this week that it has entered the medical marijuana industry with its new wholly-owned...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Involved in Numerous Clinical Trials as Company Prepares Products for Market
October 03, 2013 09:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) has several clinical trials already underway, and a host of others scheduled to commence in the company...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Enters Fourth Quarter Stronger Than Ever With Pheroid(TM) Technology
October 02, 2013 08:45 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Oct 2, 2013) - Plandaí Biotechnology Inc. (OTCQB: PLPL) already has a technology in place that is allowing it to boast of higher bioavailability with its...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces New Extract in Its Ongoing Fight Against Malaria
October 01, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 1, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces Agreement With Oasix, Inc. to Distribute Phytofare Pheroid Topical Products
September 24, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 24, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness,...
Buy Rating and New R
Buy Rating and New Report Issued for Plandai Biotechnology, Inc.
September 23, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 23, 2013) - Stock Market Media Group, a research and content development investor relations firm, has released its 3rd Quarter report and issued a Speculative Buy...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces Commencement of Clinical Trials Using Phytofare Topical Product
September 05, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 5, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnolog
Plandai Biotechnology, Inc.'s Phytofare Could Address Growing Diabetes Numbers
September 04, 2013 13:53 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) is already hard at work in Africa to develop a treatment for malaria, and it may just have a product in its...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces Completion of Production Facility, Installation of Equipment to Commence
September 04, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Product Proven to Decrease Healing Time of Sports-Related Injuries
May 21, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 21, 2013) -  In a series of articles to introduce Plandaí Biotechnology, Inc.'s (OTCQB: PLPL) three highly bioavailable products, the second of three...